Medicamentsen-ligne vous propose les traitements dont vous avez besoin afin de prendre soin de votre santé sexuelle. Avec plus de 6 ans d'expérience et plus de 90.000 clients francophones, nous étions la première clinique fournissant du acheter viagra original en France à vente en ligne et le premier vendeur en ligne de Kamagra dans le monde. Pourquoi prendre des risques si vous pouvez être sûr avec Medicamentsen-ligne - Le service auquel vous pouvez faire confiance.

6469_pharma_seminare_multiparticulate_print_multiparticulate

Oral Multiparticulate Dosage Forms – What's new?
International Association for Pharmaceutical Technology Oral Multiparticulate Dosage Forms – What's new?
Tuesday, 13th November 2012 09:00 to 18:00 h Opening remarks and scope of the workshop - Table top exhibition – Manufacturing technologies Peter KleinebuddeHeinrich-Heine-University Düsseldorf, Germany Ali R. Rajabi-SiahboomiColorcon Inc., Unites States Scale up of particle coating in the fluid bed – under- Staffan FolestadAstraZeneca AB R&D Mölndal, Sweden (not yet confirmed) Setting the scene - Formulation considerations of Janssen R&D a division of Janssen Pharmaceutica N.V., • layering vs. extrusion/spheronization• mini-matrices Case study - Micro-particles by supercritical fluids New Polymers – needs N. N.
Bayer Pharma AG, Germany (not yet confirmed) A guided city tour and a networking dinner will givethe participants the opportunity to get together. Mini-tabs for MP formulations – challenges, oppor-tunities and trendsJan LüdemannNordmark Arzneimittel GmbH & Co. KG, Germany CR pellets by melt extrusion – formulation and applicationsBrigitte SkalskyEvonik Industries AG, Pharma Polymers, Germany Industrial case study – MP formulation from lab toproductionGuido RadtkeBoehringer Ingelheim Pharma GmbH & Co. KG, Germany Industrial case study – MP tablets: Reminyl controlledrelease multiparticulatesGeert VerreckJanssen R&D a division of Janssen Pharmaceutica N.V., Belgium Wednesday, 14th November 2012 9:00 to 16:00 h • Innovative and advanced MP formulations, using PAT in particle coating Ingela Niklasson-Björn • Practical aspects of manufacturing and scale up for AstraZeneca AB R&D Mölndal, Sweden (not yet confirmed) In-vitro dissolution testing of multiparticulate systems • Up to date information on QbD and PAT aspects for Sandra KleinErnst-Moritz-Arndt-University Greifswald, Germany • Formulation considerations for the treatment of Taste masking of multiparticulatesJörg Breitkreutz Heinrich-Heine-University Düsseldorf, Germany • Table top exhibition on latest innovation in equip- Case studies IVIVC aspects of MP drug delivery systemsSandra KleinErnst-Moritz-Arndt-University Greifswald, Germany This will be an excellent opportunity for those new tothe use of multiparticulates as well as those who are Session 5: Pediactric and geriatric treatment familiar and experienced in this area. Attendees willbe able to apply their learning from this workshop to Multiparticulates – the solution for children? Jörg BreitkreutzUCL School of Pharmacy, United Kingdom You are kindly invited to submit abstracts for poster presentations during the conference. Detailed infor- mation for authors and submission are available onli-ne on the website: www.apv-mainz.de Deadline for abstract submisssion: 15th October 2012 As an exhibitor you will be also invited to attend thesessions and network at the Get Together Dinner inthe evening that is part of the conference program-me. Price for a table top space with table, chairs andpower supply is 990 EUR plus one mandatory full con-ference registration.
Please contact the APV headquarters Phone +49 6131 9769-85 e-mail sp@apv-mainz.de By postal service to:APV Arbeitsgemeinschaft fürPharmazeutische Verfahrenstechnik e.V.
Kurfürstenstraße 59D-55118 Mainz Course No. 6469Oral Multiparticulate Dosage Forms – What's new? from 13th to 14th November 2012

Source: http://apv2011-2.kundenfenster.de/fileadmin/Pdf_Programme_2012/6469_Pharma_Seminare_Multiparticulate.pdf

Förbundsinformation

Förbundsinformation bilaga til utskick nr 4/13 – avsänt den 17 oktober 2013 VIKTIGA DATUM VIKTIGT OM ”INTYG UNDER REGISTRERING” 1 december Motioner til SVERAKs årsmöte 2014 ska Det har kommit till vår kännedom att det finns klubbar som hanterar ”under reg”-intyg på helt felaktigt och inte 1 december 1:a ADVENT KATTENS DAG Om blanketten ”Registreringsanm

Microsoft word - wellbutrin_pil_nl_ib20 csp_v21_1103

BIJSLUITER: INFORMATIE VOOR DE GEBRUIKERS WELLBUTRIN XR 150 mg tabletten met gereguleerde afgifte WELLBUTRIN XR 300 mg tabletten met gereguleerde afgifte Lees goed de hele bijsluiter voordat u dit geneesmiddel gaat gebruiken - Bewaar deze bijsluiter. Misschien heeft u hem later weer nodig. Heeft u nog vragen? Neem dan contact op met uw arts of apotheker. Geef dit geneesmiddel niet

Copyright © 2010-2014 Pharmacy Pills Pdf